Factors in Deciding between Novel and Traditional Oral Anticoagulants to Prevent Embolism in Atrial Fibrillation Patients

Scanavacca, Maurício; Darrieux, Francisco

Factors in Deciding between Novel and Traditional Oral Anticoagulants to Prevent Embolism in Atrial Fibrillation Patients / Fatores na Decisão entre os Novos e os Tradicionais Anticoagulantes Orais na Prevenção de Embolia em Pacientes com Fibrilação Atrial

Scanavacca, Maurício; Darrieux, Francisco.

Scanavacca, Maurício; USP. FM. HC. São Paulo. BR
Darrieux, Francisco; USP. FM. HC. São Paulo. BR

Arq. bras. cardiol ; 106(1): 1-3, Jan. 2016.

Article in Portuguese | LILACS | ID: lil-771057

Subject(s)

Humans; Anticoagulants/administration & dosage; Atrial Fibrillation/prevention & control; Embolism/prevention & control; Administration, Oral; Atrial Fibrillation/complications; Embolism/etiology; Risk Factors; Stroke/etiology; Stroke/prevention & control; Vitamin K/antagonists & inhibitors; Warfarin/administration & dosage

Acidente Vascular Cerebral.; Anticoagulantes; Anticoagulants; Atrial Fibrillation; Embolia e Trombose; Embolism and Thrombosis; Fibrilação Atrial; Prevention; Prevenção; Stroke.

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Atrial Fibrillation / Embolism / Anticoagulants Type of study: Etiology study / Prognostic study / Risk factors Limits: Humans Language: Portuguese Journal: Arq. bras. cardiol Journal subject: Cardiology Year: 2016 Type: Article Affiliation country: Brazil Institution/Affiliation country: USP/BR

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google